572 related articles for article (PubMed ID: 36297630)
1. Updates on Responsive Drug Delivery Based on Liposome Vehicles for Cancer Treatment.
Nikolova MP; Kumar EM; Chavali MS
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297630
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery.
Majumder J; Minko T
Expert Opin Drug Deliv; 2021 Feb; 18(2):205-227. PubMed ID: 32969740
[TBL] [Abstract][Full Text] [Related]
3. Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications.
Zangabad PS; Mirkiani S; Shahsavari S; Masoudi B; Masroor M; Hamed H; Jafari Z; Taghipour YD; Hashemi H; Karimi M; Hamblin MR
Nanotechnol Rev; 2018 Feb; 7(1):95-122. PubMed ID: 29404233
[TBL] [Abstract][Full Text] [Related]
4. Light-Responsive and Dual-Targeting Liposomes: From Mechanisms to Targeting Strategies.
Agiba AM; Arreola-Ramírez JL; Carbajal V; Segura-Medina P
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338380
[TBL] [Abstract][Full Text] [Related]
5. Stimuli-responsive Polymeric Nanosystems for Therapeutic Applications.
Handa M; Singh A; Flora SJS; Shukla R
Curr Pharm Des; 2022; 28(11):910-921. PubMed ID: 34879797
[TBL] [Abstract][Full Text] [Related]
6. Stimulus-responsive liposomes for biomedical applications.
Antoniou AI; Giofrè S; Seneci P; Passarella D; Pellegrino S
Drug Discov Today; 2021 Aug; 26(8):1794-1824. PubMed ID: 34058372
[TBL] [Abstract][Full Text] [Related]
7. Recent Advancements of Stimuli-Responsive Targeted Liposomal Formulations for Cancer Drug Delivery.
Alrbyawi H; Poudel I; Annaji M; Arnold RD; Tiwari AK; Babu RJ
Pharm Nanotechnol; 2022; 10(1):3-23. PubMed ID: 35156590
[TBL] [Abstract][Full Text] [Related]
8. Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches.
Ashrafizadeh M; Delfi M; Zarrabi A; Bigham A; Sharifi E; Rabiee N; Paiva-Santos AC; Kumar AP; Tan SC; Hushmandi K; Ren J; Zare EN; Makvandi P
J Control Release; 2022 Nov; 351():50-80. PubMed ID: 35934254
[TBL] [Abstract][Full Text] [Related]
9. Stimuli-responsive chitosan-based nanocarriers for cancer therapy.
Fathi M; Sahandi Zangabad P; Majidi S; Barar J; Erfan-Niya H; Omidi Y
Bioimpacts; 2017; 7(4):269-277. PubMed ID: 29435435
[No Abstract] [Full Text] [Related]
10. Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release.
Abri Aghdam M; Bagheri R; Mosafer J; Baradaran B; Hashemzaei M; Baghbanzadeh A; de la Guardia M; Mokhtarzadeh A
J Control Release; 2019 Dec; 315():1-22. PubMed ID: 31647978
[TBL] [Abstract][Full Text] [Related]
11. Approaches to Address PK-PD Challenges of Conventional Liposome Formulation with Special Reference to Cancer, Alzheimer's, Diabetes, and Glaucoma: An Update on Modified Liposomal Drug Delivery System.
Kesharwani P; Kumari K; Gururani R; Jain S; Sharma S
Curr Drug Metab; 2022; 23(9):678-692. PubMed ID: 35692131
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound Triggering of Liposomal Nanodrugs for Cancer Therapy: A Review.
Bahutair WN; Abuwatfa WH; Husseini GA
Nanomaterials (Basel); 2022 Sep; 12(17):. PubMed ID: 36080088
[TBL] [Abstract][Full Text] [Related]
13. Liposome-based diagnostic and therapeutic applications for pancreatic cancer.
Raza F; Evans L; Motallebi M; Zafar H; Pereira-Silva M; Saleem K; Peixoto D; Rahdar A; Sharifi E; Veiga F; Hoskins C; Paiva-Santos AC
Acta Biomater; 2023 Feb; 157():1-23. PubMed ID: 36521673
[TBL] [Abstract][Full Text] [Related]
14. Polydopamine-Modified Liposomes: Preparation and Recent Applications in the Biomedical Field.
Maurelli AM; De Leo V; Catucci L
ACS Omega; 2024 Jun; 9(23):24105-24120. PubMed ID: 38882106
[TBL] [Abstract][Full Text] [Related]
15. Advanced liposome and polymersome-based drug delivery systems: Considerations for physicochemical properties, targeting strategies and stimuli-sensitive approaches.
Kansız S; Elçin YM
Adv Colloid Interface Sci; 2023 Jul; 317():102930. PubMed ID: 37290380
[TBL] [Abstract][Full Text] [Related]
16. Stimuli-responsive liposomes for drug delivery.
Lee Y; Thompson DH
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28198148
[TBL] [Abstract][Full Text] [Related]
17. Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy.
Dinakar YH; Karole A; Parvez S; Jain V; Mudavath SL
Life Sci; 2022 Dec; 310():121133. PubMed ID: 36306866
[TBL] [Abstract][Full Text] [Related]
18. Smart Stimuli-Responsive Liposomal Nanohybrid Systems: A Critical Review of Theranostic Behavior in Cancer.
Alwattar JK; Mneimneh AT; Abla KK; Mehanna MM; Allam AN
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33800292
[TBL] [Abstract][Full Text] [Related]
19. Polymeric nanocarriers as stimuli-responsive systems for targeted tumor (cancer) therapy: Recent advances in drug delivery.
Alsehli M
Saudi Pharm J; 2020 Mar; 28(3):255-265. PubMed ID: 32194326
[TBL] [Abstract][Full Text] [Related]
20. Liposomes in the Targeted Gene Therapy of Cancer: A Critical Review.
Akkewar A; Mahajan N; Kharwade R; Gangane P
Curr Drug Deliv; 2023; 20(4):350-370. PubMed ID: 35593362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
